Clinical Trials Insight: 700056268

Trial Profile

Clinical Trials Insight: 700056268

Completed
Phase of Trial: Phase III

Latest Information Update: 18 May 2010

At a glance

  • Drugs Escitalopram; Paroxetine
  • Indications Major depressive disorder
  • Focus Registrational; Therapeutic Use
  • Sponsors Mochida Pharmaceutical
  • Most Recent Events

    • 18 May 2010 New trial record
    • 17 May 2010 According to a Lundbeck A/S media release, based on the positive results of this trial, Mochida Pharmaceuticals plans to file regulatory approval for escitalopram by the first quarter 2011.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top